1.Tsokos GC: Systemic lupus erythematosus. The New England journal of medicine 2011, 365(22):2110–2121.
2.Davidson A, Bethunaickan R, Berthier C, Sahu R, Zhang W, Kretzler M: Molecular studies of lupus nephritis kidneys. Immunol Res 2015, 63(1–3):187–196.
3.Ocampo-Piraquive V, Nieto-Aristizabal I, Canas CA, Tobon GJ: Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert review of clinical immunology 2018:1–11.
4.Podolska MJ, Biermann MH, Maueroder C, Hahn J, Herrmann M: Inflammatory etiopathogenesis of systemic lupus erythematosus: an update. Journal of inflammation research 2015, 8:161–171.
5.Yap DY, Yung S, Chan TM: Lupus nephritis: An update on treatments and pathogenesis. Nephrology (Carlton) 2018, 23 Suppl 4:80–83.
6.Alarcon GS, McGwin G, Jr., Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP: Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002, 11(2):95–101.
7.Kasitanon N, Magder LS, Petri M: Predictors of survival in systemic lupus erythematosus. Medicine 2006, 85(3):147–156.
8.de Zubiria Salgado A, Herrera-Diaz C: Lupus nephritis: an overview of recent findings. Autoimmune Diseases 2012, 2012:849684.
9.Hogan J, Appel GB: Update on the treatment of lupus nephritis. Current opinion in nephrology and hypertension 2013, 22(2):224–230.
10.Haupt H, Baudner S: [Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author’s transl)]. Hoppe-Seyler’s Zeitschrift fur physiologische Chemie 1977, 358(6):639–646.
11.Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S: Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem Biophys Res Commun 2009, 382(4):776–779.
12.Serada S, Fujimoto M, Terabe F, Iijima H, Shinzaki S, Matsuzaki S, Ohkawara T, Nezu R, Nakajima S, Kobayashi T et al: Serum leucine-rich alpha–2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflamm Bowel Dis 2012, 18(11):2169–2179.
13.O’Donnell LC, Druhan LJ, Avalos BR: Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. J Leukoc Biol 2002, 72(3):478–485.
14.Zhang H, Cao J, Li L, Liu Y, Zhao H, Li N, Li B, Zhang A, Huang H, Chen S et al: Identification of urine protein biomarkers with the potential for early detection of lung cancer. Sci Rep 2015, 5:11805.
15.Chen Y, Azman SN, Kerishnan JP, Zain RB, Chen YN, Wong YL, Gopinath SC: Identification of host-immune response protein candidates in the sera of human oral squamous cell carcinoma patients. PLoS One 2014, 9(10):e109012.
16.Andersen JD, Boylan KL, Jemmerson R, Geller MA, Misemer B, Harrington KM, Weivoda S, Witthuhn BA, Argenta P, Vogel RI et al: Leucine-rich alpha–2-glycoprotein–1 is upregulated in sera and tumors of ovarian cancer patients. J Ovarian Res 2010, 3:21.
17.Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL et al: Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst 2017, 109(4).
18.Yamamoto M, Takahashi T, Serada S, Sugase T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K et al: Overexpression of leucine-rich alpha2-glycoprotein–1 is a prognostic marker and enhances tumor migration in gastric cancer. Cancer Sci 2017, 108(10):2052–2060.
19.Salo M, Roth B, Stenstrom P, Arnbjornsson E, Ohlsson B: Urinary biomarkers in pediatric appendicitis. Pediatr Surg Int 2016, 32(8):795–804.
20.Ha YJ, Kang EJ, Lee SW, Lee SK, Park YB, Song JS, Choi ST: Usefulness of serum leucine-rich alpha–2 glycoprotein as a disease activity biomarker in patients with rheumatoid arthritis. J Korean Med Sci 2014, 29(9):1199–1204.
21.Fujimoto M, Serada S, Suzuki K, Nishikawa A, Ogata A, Nanki T, Hattori K, Kohsaka H, Miyasaka N, Takeuchi T et al: Leucine-rich alpha2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin–6 biologic therapy in rheumatoid arthritis. Arthritis Rheumatol 2015, 67(8):2056–2060.
22.Ha YJ, Kang EJ, Lee SW, Park YB, Lee SK, Song JS, Choi ST: Serum leucine-rich alpha2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still’s disease. Scand J Rheumatol 2015, 44(5):399–403.
23.Honda H, Fujimoto M, Miyamoto S, Ishikawa N, Serada S, Hattori N, Nomura S, Kohno N, Yokoyama A, Naka T: Sputum Leucine-Rich Alpha–2 Glycoprotein as a Marker of Airway Inflammation in Asthma. PLoS One 2016, 11(9):e0162672.
24.Glorieux G, Mullen W, Duranton F, Filip S, Gayrard N, Husi H, Schepers E, Neirynck N, Schanstra JP, Jankowski J et al: New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis. Nephrol Dial Transplant 2015, 30(11):1842–1852.
25.Hashida T, Nakada TA, Satoh M, Tomita K, Kawaguchi R, Nomura F, Oda S: Proteome analysis of hemofilter adsorbates to identify novel substances of sepsis: a pilot study. J Artif Organs 2017, 20(2):132–137.
26.Staubach S, Pekmez M, Hanisch FG: Differential Proteomics of Urinary Exovesicles from Classical Galactosemic Patients Reveals Subclinical Kidney Insufficiency. J Proteome Res 2016, 15(6):1754–1761.
27.Suresh CP, Saha A, Kaur M, Kumar R, Dubey NK, Basak T, Tanwar VS, Bhardwaj G, Sengupta S, Batra VV et al: Differentially expressed urinary biomarkers in children withplasma. Clin Exp Nephrol 2016, 20(2):273–283.
28.Lee H, Fujimoto M, Ohkawara T, Honda H, Serada S, Terada Y, Naka T: Leucine rich alpha–2 glycoprotein is a potential urinary biomarker for renal tubular injury. Biochem Biophys Res Commun 2018, 498(4):1045–1051.
29.Wang X, Abraham S, McKenzie JAG, Jeffs N, Swire M, Tripathi VB, Luhmann UFO, Lange CAK, Zhai Z, Arthur HM et al: LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling. Nature 2013, 499(7458):306–311.
30.Gladman DD, Ibanez D, Urowitz MB: Systemic lupus erythematosus disease activity index 2000. The Journal of rheumatology 2002, 29(2):288–291.
31.Serada S, Fujimoto M, Ogata A, Terabe F, Hirano T, Iijima H, Shinzaki S, Nishikawa T, Ohkawara T, Iwahori K et al: iTRAQ-based proteomic identification of leucine-rich alpha–2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann Rheum Dis 2010, 69(4):770–774.